These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II. Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816 [TBL] [Abstract][Full Text] [Related]
25. Encephalitogenic activity of the small form of mouse myelin basic protein in the SJL/J mouse. Chou CH; Shapira R; Fritz RB J Immunol; 1983 May; 130(5):2183-6. PubMed ID: 6187842 [TBL] [Abstract][Full Text] [Related]
26. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909 [TBL] [Abstract][Full Text] [Related]
27. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026 [TBL] [Abstract][Full Text] [Related]
28. A TCR V alpha CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones. Buenafe AC; Tsu RC; Bebo B; Bakke AC; Vandenbark AA; Offner H J Immunol; 1997 Jun; 158(11):5472-83. PubMed ID: 9164970 [TBL] [Abstract][Full Text] [Related]
29. Development of reactivity to new myelin antigens during chronic relapsing autoimmune demyelination. Cross AH; Tuohy VK; Raine CS Cell Immunol; 1993 Feb; 146(2):261-9. PubMed ID: 7513616 [TBL] [Abstract][Full Text] [Related]
30. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Racke MK; Critchfield JM; Quigley L; Cannella B; Raine CS; McFarland HF; Lenardo MJ Ann Neurol; 1996 Jan; 39(1):46-56. PubMed ID: 8572666 [TBL] [Abstract][Full Text] [Related]
31. Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage. Johnson BD; Nardella JP; McConnell TJ; Mannie MD Cell Immunol; 1997 Jul; 179(1):55-65. PubMed ID: 9259772 [TBL] [Abstract][Full Text] [Related]
37. Appearance of the encephalitogenic activity in the non-encephalitogenic fraction from human brain during a prolonged storage. Pekárek J; Jedlicka P; Vepreková A; Doutlík S Z Immunitatsforsch Exp Klin Immunol; 1973 Feb; 144(5):167-71. PubMed ID: 4143157 [No Abstract] [Full Text] [Related]
38. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis. Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961 [TBL] [Abstract][Full Text] [Related]
39. THE STRUCTURE AND IMMUNOLOGIC PROPERTIES OF BASIC PROTEINS OF MYELIN. Eylar EH Ann N Y Acad Sci; 1972 Jun; 195(1):481-491. PubMed ID: 29090770 [No Abstract] [Full Text] [Related]
40. Disintegrative syndrome in young adults. Prasher V Ir J Psychol Med; 2002 Sep; 19(3):101. PubMed ID: 30440239 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]